Patrick Dallemagne

28PUBLICATIONS
84CO-AUTHORS
Medical infection agents (incl. prions)Organometallic chemistryBiomolecular modelling and designMolecular targetsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jun 17, 2026
Structure-Guided Discovery of a Nonpeptidic MT5-MMP Inhibitor.

|Apr 14, 2026
Polyfunctionalized N-Arylsulfonyl Indoles: Identification of (E)-N-Hydroxy-3-{3-[(5-(3-(piperidin-1-yl)propoxy]-1H-indol-1-yl)sulfonyl]phenyl}acrylamide (MTP150) for the Epigenetic-Based Therapy of Parkinson's Disease.

Mireia Toledano-Pinedo, Alicia Porro-Pérez, Linda Schäker-Hübner

|Apr 13, 2026
Rational Design and Evaluation of Rivastigmine-Based Pleiotropic Prodrugs for the Treatment of Alzheimer's Disease.

Valentin Travers-Lesage, Marc Since, Alice Wang

|Mar 13, 2026
An efficient step-by-step approach to select pleiotropic drug candidates against Alzheimer's disease: The discovery of neocopride.

Christophe Rochais, Cédric Lecoutey, Georgia Culley

|Aug 26, 2025
EMT-ciliary signaling in quasi-mesenchymal-stem-like cells drives therapeutic resistance and is a druggable vulnerability in triple-negative breast cancer.

Camille E Tessier, Jennifer Derrien, Aurore M M Dupuy

|Jun 07, 2025
Targeting together cholinesterases and serotonin reuptake against Alzheimer's disease.

Thomas Guiselin, Cédric Lecoutey, Christophe Rochais

Pageof 5

Frequent Collaborators

21 joint publications

Christophe Rochais

6 joint publications

Sylvie Claeysen

5 joint publications

Audrey Davis

3 joint publications

Cédric Lecoutey